Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jul 28;12(7):e060155.
doi: 10.1136/bmjopen-2021-060155.

Automated multidimensional deep learning platform for referable diabetic retinopathy detection: a multicentre, retrospective study

Affiliations
Multicenter Study

Automated multidimensional deep learning platform for referable diabetic retinopathy detection: a multicentre, retrospective study

Guihua Zhang et al. BMJ Open. .

Abstract

Objective: To develop and validate a real-world screening, guideline-based deep learning (DL) system for referable diabetic retinopathy (DR) detection.

Design: This is a multicentre platform development study based on retrospective, cross-sectional data sets. Images were labelled by two-level certificated graders as the ground truth. According to the UK DR screening guideline, a DL model based on colour retinal images with five-dimensional classifiers, namely image quality, retinopathy, maculopathy gradability, maculopathy and photocoagulation, was developed. Referable decisions were generated by integrating the output of all classifiers and reported at the image, eye and patient level. The performance of the DL was compared with DR experts.

Setting: DR screening programmes from three hospitals and the Lifeline Express Diabetic Retinopathy Screening Program in China.

Participants: 83 465 images of 39 836 eyes from 21 716 patients were annotated, of which 53 211 images were used as the development set and 30 254 images were used as the external validation set, split based on centre and period.

Main outcomes: Accuracy, F1 score, sensitivity, specificity, area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), Cohen's unweighted κ and Gwet's AC1 were calculated to evaluate the performance of the DL algorithm.

Results: In the external validation set, the five classifiers achieved an accuracy of 0.915-0.980, F1 score of 0.682-0.966, sensitivity of 0.917-0.978, specificity of 0.907-0.981, AUROC of 0.9639-0.9944 and AUPRC of 0.7504-0.9949. Referable DR at three levels was detected with an accuracy of 0.918-0.967, F1 score of 0.822-0.918, sensitivity of 0.970-0.971, specificity of 0.905-0.967, AUROC of 0.9848-0.9931 and AUPRC of 0.9527-0.9760. With reference to the ground truth, the DL system showed comparable performance (Cohen's κ: 0.86-0.93; Gwet's AC1: 0.89-0.94) with three DR experts (Cohen's κ: 0.89-0.96; Gwet's AC1: 0.91-0.97) in detecting referable lesions.

Conclusions: The automatic DL system for detection of referable DR based on the UK guideline could achieve high accuracy in multidimensional classifications. It is suitable for large-scale, real-world DR screening.

Keywords: diabetic retinopathy; medical retina; vetreoretinal.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Receiver operating characteristic curves of the main dimensional classifiers and referable DR detection. The classification performances of four subsets (training, validation, test and external validation) are shown as receiver operating characteristic curves and AUC for detection of referable retinopathy (A), referable maculopathy (B), image-level referable DR (C) and photocoagulation (D). Notably, the detection of referable DR on an image (D) was automatically generated by integrating the results of referable retinopathy and referable maculopathy. AUC, area under receiver operating characteristic curve; DR, diabetic retinopathy.
Figure 2
Figure 2
Visualisation by the SHAP-CAM heatmap technique for referable DR lesions. The original images are displayed in the first column, the combined heatmaps generated by SHAP-CAM are shown in the last column, and the heatmaps by CAM and DeepSHAP are shown in the second and third columns for comparison, respectively. (A) Vitreous haemorrhage located on the temporal-superior retina of the original image with the centred macula, suggesting the R3 degree of DR. The CAM heatmap showed a rough location as a wide red-cyan area for the lesion, while the DeepSHAP heatmap demonstrated dispersed dots with some irrelevant noises. The SHAP-CAM heatmap retained an light pink background area, with similar size as that of CAM, and depicted a deeper red clear lesion, same as that of DeepSHAP, in the background. The residue area was masked by CAM as white to reduce inference of redundant information. (B) Retinopathy of R2, including venous beading, intraretinal microvascular abnormality and multiple blot haemorrhages, located around the optic disc on original images. The CAM heatmap showed a rough area for detection, whereas the DeepSHAP heatmap indicated the optic disc as a lesion. For the SHAP-CAM heatmap, all key lesions are depicted in the accurate light pink area without involving the optic disc and macula. (C) The original image showed a referable maculopathy with multiple exudates involving the centre of the fovea. The SHAP-CAM heatmap accurately predicted the shape/outline of the lesions in the macula area, whereas CAM only visualised the lesions by a wide red-cyan circle area and the DeepSHAP showed several light noises out of the macula. DR, diabetic retinopathy.

Similar articles

Cited by

References

    1. Flaxman SR, Bourne RRA, Resnikoff S, et al. . Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e1221–34. 10.1016/S2214-109X(17)30393-5 - DOI - PubMed
    1. Saeedi P, Petersohn I, Salpea P, et al. . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. 10.1016/j.diabres.2019.107843 - DOI - PubMed
    1. Teo ZL, Tham Y-C, Yu M, et al. . Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 2021;128:1580–91. 10.1016/j.ophtha.2021.04.027 - DOI - PubMed
    1. Bachmann MO, Nelson SJ. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 1998;52:45–52. 10.1136/jech.52.1.45 - DOI - PMC - PubMed
    1. Wormald R, Courtney P. Prevention of blindness by screening for diabetic retinopathy. BMJ 1989;299:1528. 10.1136/bmj.299.6714.1528-b - DOI - PMC - PubMed

Publication types